Distinct cortical thickness patterns link disparate cerebral cortex regions to select mobility domains.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 03 2021
Historique:
received: 10 05 2020
accepted: 19 02 2021
entrez: 24 3 2021
pubmed: 25 3 2021
medline: 15 10 2021
Statut: epublish

Résumé

The cortical control of gait and mobility involves multiple brain regions. Therefore, one could speculate that the association between specific spatial patterns of cortical thickness may be differentially associated with different mobility domains. To test this possibility, 115 healthy participants aged 27-82 (mean 60.5 ± 13.8) underwent a mobility assessment (usual-walk, dual-task walk, Timed Up and Go) and MRI scan. Ten mobility domains of relatively simple (e.g., usual-walking) and complex tasks (i.e., dual task walking, turns, transitions) and cortical thickness of 68 ROIs were extracted. All associations between mobility and cortical thickness were controlled for age and gender. Scaled Subprofile Modelling (SSM), a PCA-regression, identified thickness patterns that were correlated with the individual mobility domains, controlling for multiple comparisons. We found that lower mean global cortical thickness was correlated with worse general mobility (r = - 0.296, p = 0.003), as measured by the time to complete the Timed Up and Go test. Three distinct patterns of cortical thickness were associated with three different gait domains during simple, usual-walking: pace, rhythm, and symmetry. In contrast, cortical thickness patterns were not related to the more complex mobility domains. These findings demonstrate that robust and topographically distinct cortical thickness patterns are linked to select mobility domains during relatively simple walking, but not to more complex aspects of mobility. Functional connectivity may play a larger role in the more complex aspects of mobility.

Identifiants

pubmed: 33758214
doi: 10.1038/s41598-021-85058-z
pii: 10.1038/s41598-021-85058-z
pmc: PMC7988162
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

6600

Subventions

Organisme : NIA NIH HHS
ID : R01 AG038465
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG038465
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG026158
Pays : United States
Organisme : NIA NIH HHS
ID : F32 AG053035
Pays : United States

Références

Clin Neurophysiol. 2014 May;125(5):995-1005
pubmed: 24210997
Neuroimage. 2014 Dec;103:139-151
pubmed: 25245813
Brain Topogr. 2017 Mar;30(2):272-280
pubmed: 27785698
J Alzheimers Dis. 2019;71(s1):S1-S4
pubmed: 31476163
Front Neurol. 2018 Oct 29;9:913
pubmed: 30425679
Arch Phys Med Rehabil. 2011 May;92(5):844-6
pubmed: 21530734
J Am Geriatr Soc. 2014 Apr;62(4):673-8
pubmed: 24635699
PLoS One. 2015 May 06;10(5):e0124797
pubmed: 25945925
Front Hum Neurosci. 2013 Jan 10;6:356
pubmed: 23335895
J Psychiatry Neurosci. 2010 May;35(3):163-76
pubmed: 20420767
J Gerontol A Biol Sci Med Sci. 2019 Mar 14;74(4):500-506
pubmed: 29300849
J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1176-1183
pubmed: 31246244
Front Aging Neurosci. 2014 Aug 25;6:217
pubmed: 25202270
Mov Disord. 2008 Feb 15;23(3):329-42; quiz 472
pubmed: 18058946
Neurorehabil Neural Repair. 2016 Nov;30(10):963-971
pubmed: 27221042
Exp Gerontol. 2015 Jan;61:98-104
pubmed: 25446977
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):149-162
pubmed: 28115194
J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1380-8
pubmed: 19126852
Neuroimage. 2018 Sep;178:36-45
pubmed: 29772378
Neuroimage. 2016 Nov 15;142:293-300
pubmed: 27353567
PLoS One. 2014 Jan 08;9(1):e84909
pubmed: 24416309
Hum Brain Mapp. 2014 Jun;35(6):2817-35
pubmed: 24142374
J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):929-35
pubmed: 17237140
Brain. 2011 Oct;134(Pt 10):3094-105
pubmed: 21685458
Neuroimage. 2016 Aug 15;137:165-177
pubmed: 27236083
Physiol Meas. 2011 Dec;32(12):2003-18
pubmed: 22094550
PLoS One. 2020 Mar 25;15(3):e0230298
pubmed: 32210453
Physiol Meas. 2016 Sep 21;37(10):1785-1797
pubmed: 27653760
Parkinsonism Relat Disord. 2019 Aug;65:190-196
pubmed: 31272924
Nat Neurosci. 2013 Mar;16(3):325-31
pubmed: 23396102
Front Psychol. 2012 May 10;3:141
pubmed: 22593748
Front Hum Neurosci. 2015 Jun 30;9:360
pubmed: 26175677
Cereb Cortex. 2005 Jul;15(7):986-94
pubmed: 15513929
J Gerontol A Biol Sci Med Sci. 2010 Oct;65(10):1086-92
pubmed: 20484336
JAMA. 2011 Jan 5;305(1):50-8
pubmed: 21205966
Nat Rev Neurosci. 2009 Jan;10(1):59-70
pubmed: 19096369
Neurobiol Aging. 2019 Nov;83:124-129
pubmed: 31732015
J Mov Disord. 2017 Jan;10(1):1-17
pubmed: 28122432
Brain Res. 2009 Sep 29;1291:73-81
pubmed: 19631621
Gerontology. 2016;62(5):500-7
pubmed: 26974848
J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):705-713
pubmed: 29846517
Eur Rev Aging Phys Act. 2019 May 3;16:6
pubmed: 31073340
J Am Geriatr Soc. 2012 Nov;60(11):2127-36
pubmed: 23110433
Nat Rev Neurosci. 2010 Nov;11(11):760-72
pubmed: 20944662
Gait Posture. 2013 Apr;37(4):500-5
pubmed: 23018028
Neuroimage. 2009 Nov 1;48(2):371-80
pubmed: 19559801
Alzheimers Dement. 2013 Jul;9(4):406-13
pubmed: 23141384
Neurosci Biobehav Rev. 2019 May;100:344-369
pubmed: 30552912
Parkinsonism Relat Disord. 2016 Apr;25:91-6
pubmed: 26861167
Neuroimage. 2005 Jan 1;24(1):163-73
pubmed: 15588607
Neuropsychologia. 2009 May;47(6):1434-48
pubmed: 19138694
J Gerontol A Biol Sci Med Sci. 2013 Jul;68(7):820-7
pubmed: 23250001
Neurorehabil Neural Repair. 2013 Oct;27(8):742-52
pubmed: 23774124
Mov Disord. 2013 Oct;28(12):1683-90
pubmed: 24123150
Alzheimers Dement. 2020 Sep;16(9):1305-1311
pubmed: 30222945
Neuropsychologia. 2018 Jun;114:50-64
pubmed: 29655800
Neuroimage. 2012 Jan 16;59(2):1478-84
pubmed: 21854857
J Gerontol A Biol Sci Med Sci. 2014 Nov;69(11):1375-88
pubmed: 24739495
Cogn Affect Behav Neurosci. 2002 Mar;2(1):64-75
pubmed: 12452585
Brain Topogr. 2014 Mar;27(2):293-5
pubmed: 23681340
Brain. 2017 May 1;140(5):1384-1398
pubmed: 28335024
Neuroradiology. 2015 Aug;57(8):851-61
pubmed: 25921321
Gait Posture. 2014 Sep;40(4):487-92
pubmed: 25085660
Brain Cogn. 2017 Jul;115:41-46
pubmed: 28433922

Auteurs

Inbal Maidan (I)

Laboratory of Early Markers of Neurodegeneration, Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, 64239, Tel Aviv, Israel. inbalm@tlvmc.gov.il.
Department of Neurology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. inbalm@tlvmc.gov.il.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. inbalm@tlvmc.gov.il.

Anat Mirelman (A)

Laboratory of Early Markers of Neurodegeneration, Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, 64239, Tel Aviv, Israel.
Department of Neurology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

Jeffrey M Hausdorff (JM)

Laboratory of Early Markers of Neurodegeneration, Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, 64239, Tel Aviv, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Department of Physical Therapy, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Orthopaedic Surgery, Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.

Yaakov Stern (Y)

Cognitive Neuroscience Division of the Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain and G.H. Sergievsky Center, Columbia University Irving Medical Center, New York, NY, USA.

Christian G Habeck (CG)

Cognitive Neuroscience Division of the Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain and G.H. Sergievsky Center, Columbia University Irving Medical Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH